Secondaries announced 7.29.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Genocea Biosciences, Inc.
Symbol: GNCA
Price: Last trade $13.91
Trade Date: 7/30
Shares: 3.6 million
Underwriter(s) Cowen & Co., Piper Jaffray, Stifel
Co Manager(s) Needham & Co.
Rating=Subscription Needed